Galectin Therapeutics Stock (NASDAQ: GALT) stock price, news, charts, stock research, profile.
You can purchase shares of Galectin Therapeutics (NASDAQ:GALT) through any online brokerage.
Other companies in Galectin Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA) and Adverum Biotechnologies (NASDAQ:ADVM).
Galectin Therapeutics has a consensus price target of $11.00.
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.63 last updated September 25, 2024 at 2:49 PM EDT.
There are no upcoming dividends for Galectin Therapeutics.
Galectin Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Galectin Therapeutics.
Galectin Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.